Vesence | $9,000,000 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
CYRISMA
United States
- Rochester, NY
- 10/10/2024
- Series A
- $7,000,000
CYRISMA™ is a revolutionary cybersecurity platform that helps organizations manage risk without the usual headaches associated with enterprise cybersecurity tools. Designed for organizations that demand a clear and immediate return on investment, CYRISMA™ simplifies the process of identifying, assessing, and mitigating technical risks, all while eliminating high licensing costs, long deployment times, and burdensome technologies. Our data-centric approach to cybersecurity streamlines your cybersecurity efforts by focusing on what’s important while providing a simple, easy-to-use platform for identifying risks, strengthening weak configurations, and neutralizing risks through accountability. We are the simple choice for effective cybersecurity.
- Industry Computer & Network Security
- Website https://www.cyrisma.com/
- LinkedIn https://www.linkedin.com/company/cyrisma/
Related People
Oliver DownwardFounder
United Kingdom -
ND
I am an accomplished executive leader with over a decade of experience in diverse industries. Currently serving as the Chief Executive Officer at CYRISMA, I provide strategic leadership and direction, building on my prior role as Chief Operating Officer where I excelled in operational oversight, budget management, and compliance. My career includes achievements such as record-breaking promotions, B2B relationship building, and aligning CRM strategies with marketing initiatives. I have a strong background in regulatory compliance, with a commitment to innovation and process improvement. My multifaceted expertise and ability to drive results make me a valuable asset in executive leadership positions.
Mem0 | $24,000,000 | (Oct 30, 2025)
Valthos | $30,000,000 | (Oct 30, 2025)
Mondra | $13,206,500 | (Oct 30, 2025)
hoop.dev | Undisclosed Amount | (Oct 30, 2025)
IORGANBIO | $2,000,000 | (Oct 30, 2025)
FrontlineIQ | $3,300,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
VentureMed Inc. | $28,000,000 | (Oct 30, 2025)
Recess | $30,000,000 | (Oct 30, 2025)